Received Apr 13, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (UNKNOWN)) | UNKNOWN MANUFACTURER | 1 | 3052733 | IM / LA |
Site: Bruising at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Swelling at Injection Site-Medium, Systemic: Autoimmune Disease (diagnosed by MD)-Medium, Systemic: Neurological Disorder (diagnosed by MD)-Medium, Additional Details: Flare of Rheumatoid arthritis that has not subsided. Multiple steroid therapy. Documenting for purpose of long term rheumatoid arthitis that developed after Mnexspike vaccine. , Other Vaccines: VaccineTypeBrand: Fluad; Manufacturer: Seqirus; LotNumber: 407264; Route: Intramuscularly; BodySite: Right Deltoid; Dose: ; VaxDate: UNKNOWN